Document is current
Any future updates will be listed below
-
Authors
Jandová, Marie
Litvik, Radek
Tichý, Martin
Gkalpakiotis, Spyridon
-
Funding
Funding for this research was provided by:
Medical writing and Rapid Service Fees were sponsored by Almirall S.A.
- License Information
-
More Information
Article History
Received: 19 September 2025
Accepted: 20 November 2025
First Online: 5 December 2025
Declarations
:
: Marie Jandová is consultant from Abbvie and Almirall. Radek Litvik has been advisor and/or speaker from Almirall, Pierre Fabre, and Recordati. Martin Tichý has been advisor and/or speaker and/or participated in clinical trials from Abbvie, Almirall, BMS, Eli Lilly, Janssen—Cilag, Leo Pharma, Novartis, Sanofi Genzyme, UCB. Spyridon Gkalpakiotis has been advisor and/or speaker from Almirall, Abbvie, LEO Pharma, UCB, Janssen Cilaq, Pfizer, Novartis, Eli-Lilly, Sanofi and an investigator from Almirall, Abbvie, LEO Pharma, UCB, Janssen Cilaq, Pfizer, Novartis, Eli-Lilly, Sanofi, NEKTAR, and Alumis.
: Written informed consent was obtained from the patients for publication of this case series and any accompanying images. The study was conducted in strict accordance with the Declaration of Helsinki, ensuring adherence to ethical standards and respecting patient privacy.
